Patents Assigned to Ceapro INC
-
Patent number: 8815268Abstract: A simple and efficient method for the production of stable, clear, high-potency oat extracts is disclosed. The method employs the use of differential dissociation constants and ultrafiltration to stabilise extracts, prevent hazing, and prevent the loss of functional activity as an anti-irritant and anti-oxidant. Also disclosed are compositions of oat extracts derived from whole oat grains and oatmeal. Further disclosed are compositions of oat extracts for use in cosmetic, nutraceutical, therapeutic medical and veterinary preparations.Type: GrantFiled: August 2, 2013Date of Patent: August 26, 2014Assignee: CEAPRO, Inc.Inventors: Mark J. Redmond, David A. Fielder
-
Patent number: 8632798Abstract: Cereal ?(1-3) ?(1-4) glucan is used as a film or coating agent to produce clear, edible, biodegradable, delivery, lubricating, and protecting agents. Cereal ?(1-3) ?(1-4) glucans are distinctive polymers of glucose differentiated from other polymers by not only their source but also their physicochemical properties. The ?(1-3) ?(1-4) forms a matrix to sequester other materials, such as pharmaceutical, medical and therapeutic agents, flavors, fragrances. The technology has applications to essential oils and non-aqueous materials that are rendered deliverable by the ?(1-3) ?(1-4) glucan. The ?(1-3) ?(1-4) glucan films described may be consumed whereby they dissolve in the mouth in a controlled manner and may be used for the delivery of pharmaceutical, medical or confectionery products.Type: GrantFiled: March 3, 2010Date of Patent: January 21, 2014Assignee: Ceapro Inc.Inventors: Mark J. Redmond, David A. Fielder
-
Patent number: 8512719Abstract: A simple and efficient method for the production of stable, clear, high-potency oat extracts is disclosed. The method employs the use of differential dissociation constants and ultrafiltration to stabilize extracts, prevent hazing, and prevent the loss of functional activity as an anti-irritant and anti-oxidant. Also disclosed are compositions of oat extracts derived from whole oat grains and oatmeal. Further disclosed are compositions of oat extracts for use in cosmetic, nutraceutical, therapeutic medical and veterinary preparations.Type: GrantFiled: January 25, 2011Date of Patent: August 20, 2013Assignee: Ceapro Inc.Inventors: Mark J. Redmond, David A. Fielder
-
Publication number: 20110118352Abstract: A simple and efficient method for the production of stable, clear, high-potency oat extracts is disclosed. The method employs the use of differential dissociation constants and ultrafiltration to stabilise extracts, prevent hazing, and prevent the loss of functional activity as an anti-irritant and anti-oxidant. Also disclosed are compositions of oat extracts derived from whole oat grains and oatmeal. Further disclosed are compositions of oat extracts for use in cosmetic, nutraceutical, therapeutic medical and veterinary preparations.Type: ApplicationFiled: January 25, 2011Publication date: May 19, 2011Applicant: CEAPRO, INC.Inventors: Mark J. REDMOND, David A. Fielder
-
Publication number: 20110059031Abstract: The present invention relates to oral compositions comprising a ? (1-3) ? (1-4) glucan and one, or more than one compound of interest. In particular, the present invention provides an oral composition comprising an effective amount of a ? (1-3) ? (1-4) glucan and an effective amount of one, or more than one of an antibacterial agent, a botanical extract, and a flavouring agent, and also provides a method of using this composition for maintaining fresh breath in a subject over a prolonged period of time.Type: ApplicationFiled: November 12, 2010Publication date: March 10, 2011Applicant: CEAPRO INC.Inventors: Mark J. Redmond, David A. Fielder
-
Patent number: 7887823Abstract: A simple and efficient method for the production of stable, clear, high-potency oat extracts is disclosed. The method employs the use of differential dissociation constants and ultrafiltration to stabilize extracts, prevent hazing, and prevent the loss of functional activity as an anti-irritant and anti-oxidant. Also disclosed are compositions of oat extracts derived from whole oat grains and oatmeal. Further disclosed are compositions of oat extracts for use in cosmetic, nutraceutical, therapeutic medical and veterinary preparations.Type: GrantFiled: July 29, 2004Date of Patent: February 15, 2011Assignee: CEAPRO, Inc.Inventors: Mark J. Redmond, David A. Fielder
-
Publication number: 20100303921Abstract: The present invention relates to pharmaceutical compositions comprising a ? (1-3) ? (1-4) glucan and a pharmaceutically active agent or a botanical extract. A method to extract and purify cereal ?-glucan is also described. The high purity of the cereal ?-glucan obtained according to the present invention allows for the preparation of clear, colourless viscous liquid preparations. These liquid preparations are stable to gelling effects when kept at ambient temperatures and low ash concentrations, and can be used to prepare the pharmaceutical compositions of the present invention.Type: ApplicationFiled: June 29, 2010Publication date: December 2, 2010Applicant: CEAPRO, INC.Inventors: Mark J. Redmond, David A. Fielder
-
Publication number: 20100267662Abstract: Methods and compositions for treating or preventing a skin condition, an inflammation, an irritation or an allergy associated with an ectoparasitic infection or infestation on an animal.Type: ApplicationFiled: November 6, 2008Publication date: October 21, 2010Applicant: CEAPRO, INC.Inventors: David A. Fielder, Mark J. Redmond, Ian W. Cottrell
-
Publication number: 20100158988Abstract: Cereal ?(1-3) ?(1-4) glucan is used as a film or coating agent to produce clear, edible, biodegradable, delivery, lubricating, and protecting agents. Cereal ?(1-3) ?(1-4) glucans are distinctive polymers of glucose differentiated from other polymers by not only their source but also their physicochemical properties. The ?(1-3) ?(1-4) forms a matrix to sequester other materials, such as pharmaceutical, medical and therapeutic agents, flavours, fragrances. The technology has applications to essential oils and non-aqueous materials that are rendered deliverable by the ?(1-3) ?(1-4) glucan. The ?(1-3) ?(1-4) glucan films described may be consumed whereby they dissolve in the mouth in a controlled manner and may be used for the delivery of pharmaceutical, medical or confectionery products.Type: ApplicationFiled: March 3, 2010Publication date: June 24, 2010Applicant: CEAPRO, INC.Inventors: Mark J. Redmond, David A. Fielder
-
Publication number: 20060251590Abstract: The present invention relates to oral compositions comprising a ?(1-3) ?(1-4) glucan and one, or more than one compound of interest. In particular, the present invention provides an oral composition comprising an effective amount of a ?(1-3) ?(1-4) glucan and an effective amount of one, or more than one of an antibacterial agent, a botanical extract, and a flavouring agent, and also provides a method of using this composition for maintaining fresh breath in a subject over a prolonged period of time.Type: ApplicationFiled: April 30, 2004Publication date: November 9, 2006Applicant: Ceapro Inc.Inventors: Mark Redmond, David Fielder
-
Publication number: 20060188443Abstract: A solid oral diagnostic test meal is provided that contains a polysaccharide, wherein the oral diagnostic test meal provides a medically controlled quantity of glycemic carbohydrate after being ingested by a vertebrate subject. In addition, methods and kits are provided for using the diagnostic test meal to monitor postprandial glucose to screen insulin levels and/or diagnose disorders of carbohydrate metabolism, to manage subjects being treated with antidiabetic agents, to self-diagnose diabetes and self-manage diet and antidiabetic drug dosage, and to calculate the glycemic index of a test food.Type: ApplicationFiled: August 16, 2004Publication date: August 24, 2006Applicant: Ceapro Inc.Inventors: Mark Redmond, Diana Shaw
-
Publication number: 20060121131Abstract: The present invention relates to pharmaceutical compositions comprising a ? (1-3)? (1-4) glucan and a pharmaceutically active agent or a botanical extract. A method to extract and purify cereal ?-glucan is also described. The high purity of the cereal ?-glucan obtained according to the present invention allows for the preparation of clear, colourless viscous liquid preparations. These liquid preparations are stable to gelling effects when kept at ambient temperatures and low ash concentrations, and can be used to prepare the pharmaceutical compositions of the present invention.Type: ApplicationFiled: April 30, 2004Publication date: June 8, 2006Applicant: Ceapro Inc.Inventors: Mark Redmond, David Fielder
-
Publication number: 20060122149Abstract: A novel method to extract and purify cereal ?-glucan is described. Cereal ? glucans are distinctive polymers of glucose differentiated from other polymers not only by their source but also by their physicochemical properties. The high purity of the cereal ?-glucan obtained according to the present invention allows for the preparation of clear, colourless viscous liquid preparations. These liquid preparations are stable to gelling effects when kept at ambient temperatures and low ash concentrations. Compositions comprising ? (1-3) ? (1-4) glucan and a freezing point depressant are also, described.Type: ApplicationFiled: April 30, 2004Publication date: June 8, 2006Applicant: Ceapro Inc.Inventors: Mark Redmond, David Fielder
-
Publication number: 20050031674Abstract: Cereal ?(1?3) ?(1?3) glucan is used as a film or coating agent to produce clear, edible, biodegradable, delivery, lubricating, and protecting agents. Cereal ?(1?3) ?(1?4) glucans are distinctive polymers of glucose differentiated from other polymers by not only their source but also their physicochemical properties. The ?(1?3) ?(1?4) forms a matrix to sequester other materials, such as pharmaceutical, medical and therapeutic agents, flavours, fragrances. The technology has applications to essential oils and non-aqueous materials that are rendered deliverable by the ?(1?3) ?(1?4) glucan. The ?(1?3) ?(1?4) glucan films described may be consumed whereby they dissolve in the mouth in a controlled manner and may be used for the delivery of pharmaceutical, medical or confectionery products.Type: ApplicationFiled: December 11, 2002Publication date: February 10, 2005Applicant: CEAPRO, INCInventors: Mark Redmond, David Fielder
-
Patent number: 6818232Abstract: A simple and efficient method for the production of a stable, clear and high-potency oat extract, containing avenanthramide, is disclosed. The method employs the use of a differential dissociation constants and ultra filtration to stabilize extract, prevent the loss of functional activity as an anti-irritant and anti-oxidant.Type: GrantFiled: November 6, 2001Date of Patent: November 16, 2004Assignee: Ceapro, Inc.Inventors: Mark J. Redmond, David A. Fielder
-
Patent number: 6284886Abstract: Simple and efficient methods for formulating cereal beta glucan compositions that retard the natural gel forming properties of hydrocolloids and remain free flowing liquids is disclosed. The method employs a biological buffer system consisting of a zwitterionic salt that will vary pH with temperature. The resulting beta glucan preparation can be used directly or stored for future use.Type: GrantFiled: May 26, 1999Date of Patent: September 4, 2001Assignee: Ceapro INCInventor: Mark J. Redmond